About this trial
Maternal diet influences breast milk nutritional profile; however, a national survey undertaken by the researchers revealed that non-for-profit donor milk banks in the U.K. do not provide specific dietary information to donors. Moreover, the researchers have shown that donor milk in the U.K. provides very low levels of the omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), docosahexaenoic acid (DHA) and arachidonic acid, respectively. These are essential for brain development and immune system function, and preterm infants receiving donor milk do not receive sufficient levels of these nutrients. There is therefore an urgent need to develop nutritional guidelines and resources for milk donors.
Following a systematic review the researchers developed evidence-based nutritional information resources for donors, which would also be applicable more generally to lactating mothers. Those resources were developed in consultation with donors, and healthcare professionals, including dietitians and lactation consultants.
Researchers will evaluate the effectiveness of these resources in terms of acceptance and compliance, and also changes in milk DHA content. The researchers will also assess whether providing feedback on individual's milk DHA content increases milk DHA levels. If successful these resources will be introduced into milk banks across the U.K., and promoted to the wider breastfeeding community.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
Insufficient comprehension of English to understand the information sheet and consent form and complete the questionnaires
Currently taking omega-3 PUFA dietary supplements providing greater than 200 mg DHA per day
Body Mass Index (BMI) ≥30 kg/m2
Trial design
Parallel
Treatments tested in this trial
Nutritional resources
Other interventionThe participants will be provided with the nutritional resources only.
Milk docosahexaenoic acid levels
Other interventionThe participants will be provided with information on the levels of docosahexaenoic acid in their breast milk.
Treatment groups
Trial outcomes
Primary outcomes
Content of omega-3 fatty acids in the participants diet
The omega-3 fatty acid content of the participants diet will be assessed from three-day photo-diet diaries taken at the start and end of the study. The participants will use their own mobile phone with a phone application, such as FoodView to record their meals. The omega-3 fatty acid values for alpha-linolenic acid, eicosapentaenoic acid and docosahexaenoic will then be calculated in mg/day from these images using nutrient analysis software, such as Dietplan, and intake levels will be compared between the baseline and endpoint values.
Secondary outcomes
Concentration of docosahexaenoic acid in the participants breast milk
The concentration of docosahexaenoic acid in the participants breast milk will be measured by gas chromatography from samples taken at the start and end of the study.
Concentration of omega-3 fatty acids in the participants blood
The omega-3 fatty acid concentration of the participants non-fasted blood will be assessed by measuring the docosahexaenoic and eicosapentaenoic acid levels from pin-prick whole-blood samples taken at the start and end of the study. The samples will be analysed by gas chromatography.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Roehampton
Lead sponsor
Countess of Chester NHS Foundation Trust
Collaborator